Immunity and health – Research & Development

Monday, 19 December 2011 2:40 The clinical effectiveness of BioBran in immunotherapy for patients with hepatitis B BioBran is a food supplement that is combined with conventional treatment to improve the outcome of the disease. There were 3 cases of viral B hepatitis patients who have treated by the combination of conventional antiviral...
Read more
Friday, 30 September 2011 8:09 Maternal-fetal distribution and transfer of dioxins in pregnant Women in Japan, and attempts to reduce maternal transfer with Chlorella (Chlorella pyrenoidosa) supplements Abstract: Dioxins can be transferred from mother to fetus via the placenta, or to nursing infants via breast milk, potentially causing developmental health problems in children. To assess pediatric health risks from dioxins, exposure of mothers...
Read more
Friday, 01 October 2010 7:53 Arabinoxylan Rice Bran (MGN-3) Enhances the Effects of Interventional Therapies for the Treatment of Hepatocellular Carcinoma: A Three-year Randomized Clinical Trial Abstract. Background and Aims: This study examined the efficacy of arabinoxylan rice bran (MGN-3) in conjunction with an interventional therapy (IT) for the treatment of hepatocellular carcinoma patients. Patients and Methods: A total of sixty-eight patients...
Read more
Sunday, 07 June 2009 8:15 Epigenetics and Immurmsenescence Reversal: An Evidence-Based Longevity Paradigm Abstract: Humankind has long thought of aging as a gradual, time—dependent, deterioration in one‘s well-being and quality of life, with an increased incidence and severity of debilitating chronic diseases. However, current medical opinion argues for a...
Read more
Wednesday, 17 September 2008 8:48 BioBran – augmented maturation of human monocyte – derived dendritic cells Abstract: BioBran, enzymatically modified arabinoxylan from rice bran was tested for its possible effects on in vitro matumtion of human dendritic cells (DC). lmmature DC (iDC) derived from plastic-adhered, lL-4 and GM-CSF treated peripheral monocytes (Mo)...
Read more
Monday, 11 February 2008 7:32 MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunombicin. Abstract: Background: MGN-3/Biobran, a modified form of arabinoxylan from rice bran, is a potent biological response modifier (BRM). Our previous studies demonstrated that MGN-3 sensitizes human leukemia cells to death receptor [CD95]-induced apoptosis [Ghoneum M, Gollapudi...
Read more
Tuesday, 23 October 2007 9:15 Modified Arabinoxylan Rice Bran (MGN-3/BioBran) enhances Intracellular killing of microbes by human Phagocytic cells In Vitro Abstract: Phagocytic cells, comprised of neutrophils and moncytyes/macrophages, play a key role in the innate immune response to infection. Our earlier study demonstrated that arabinoxylan rice bran (MGN-3/Biobran) activates murine peritoneal macrophage and macrophage cell lines....
Read more
Friday, 08 June 2007 7:56 Yeast therapy for the treatment of cancer and its enhancement by MGN-3/BioBran, an Arabinoxylan rice bran Abstract: Apoptosis constitutes a strictly programmed device for the removal of aged, damaged and abnormal cells. Research in the last decade has revealed a promising future for apoptosis-based cancer therapies. However, chemotherapeutic agents exhibit an indiscriminative...
Read more
Monday, 07 May 2007 9:40 In Vivo Tumor lnhibitory Effects of Nutritional Rice Bran Supplement MGN-3/Biobran on Ehrlich Carcinoma-Bearing Mice. Abstract: This study was undertaken to investigate the in vivo anti-tumor activity of MGN-3/Biobran, a modified arabinoxylan rice bran. Swiss albino mice were inoculated intramuscularly in the right thigh with Ehrlich ascites carcinoma (EAC) cells. On...
Read more